BAUDAX BIO, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0105 USD | 0.00% |
|
-4.55% | -52.27% |
| Feb. 22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
| 2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Chart calendar Baudax Bio, Inc.
3c060421142eb7090881a75.dr2_87DS1EXWT2p_0KOvEHpVYnoL5NySu5GN_Igcyhg.Jejpu_j_pAeAN1JG6OTWaBQlF1d8ge7ejvzLqutesG8h8OWp77HgdqQFMw~181ddc9a1389b062748a6ffe78e1d084
Upcoming events on Baudax Bio, Inc.
Past events on Baudax Bio, Inc.
| 2023-10-12 10:00 am | Extraordinary Shareholders Meeting |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-16 08:00 am | Q2 2023 Earnings Release |
| 2023-06-23 09:00 am | Annual General Meeting |
| 2023-05-10 01:45 pm | Sidoti Micro-Cap Virtual Conference |
| 2023-05-09 | Investor Meeting |
| 2023-04-25 10:00 am | Investor Meeting - Key Opinion Leader |
| 2023-03-12 | Investor Meeting |
| 2023-02-23 08:00 am | FY 2022 Earnings Release |
| 2023-02-01 12:00 am | Channelchek Takeaway Series - The J.P.Morgan Healthcare Conference |
| 2022-11-08 04:09 pm | Q3 2022 Earnings Release |
| 2022-11-02 | Extraordinary Shareholders Meeting |
| 2022-09-14 03:00 pm | H.C. Wainwright Global Investment Conference |
| 2022-08-11 07:00 am | Interim 2022 Earnings Release |
| 2022-08-10 | Interim 2022 Earnings Call |
| 2022-05-25 01:30 pm | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-18 09:00 am | Annual General Meeting |
| 2022-05-05 05:00 pm | Q1 2022 Earnings Release |
| 2022-05-05 08:30 am | Q1 2022 Earnings Call |
| 2022-04-21 10:45 am | NobleCon18 Conference - Breakout Session - 2 |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,49 2,03 -75.75% | 1,08 1,32 -17.87% | 1,27 0,96 32.19% |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -32,0 -46,2 30.65% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -73,5 | -32,5 -33,0 1.32% | -74,8 -72,9 -2.59% | -19,0 -61,4 69.04% | -56,8 -53,2 -6.84% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -32,6 -33,0 1.34% | -76,1 -74,9 -1.6% | -22,2 -43,6 49.07% | -58,8 -55,3 -6.28% |
|
Net income Million USD | Released Forecast Spread | 0,00 | -32,6 -33,0 1.34% | -76,1 -74,9 -1.6% | -22,2 -43,6 49.07% | -58,8 -55,3 -6.28% |
|
EPS USD | Released Forecast Spread | 0,00 | -4 872 -5 082 4.13% | -5 502 -5 810 5.3% | -406 -761 46.69% | -177 -189 6.39% |
| Announcement Date | 08/11/19 | 13/02/20 | 16/02/21 | 16/03/22 | 23/02/23 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,28 0,60 -53.17% | 0,40 0,63 -36% | 0,42 0,58 -26.86% | 0,30 0,77 -61.19% | 0,24 0,97 -75.34% | 0,31 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -16,4 -12,5 -31.57% | 30,0 -12,4 342.57% | -6,97 -9,64 27.65% | -8,60 -4,97 -73.21% | -4,69 15,4 -130.37% | -7,05 -4,80 -46.77% | -1,78 -4,60 61.39% | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,0 -13,0 -30.98% | 27,0 5,63 380% | -7,53 -9,64 21.85% | -9,25 -5,77 -60.18% | 11,4 14,9 -23.6% | -7,30 -5,31 -37.52% | |||
|
Net income Million USD | Released Forecast Spread | -17,0 -13,0 -30.98% | 27,0 5,63 380% | -7,53 -9,64 21.85% | -9,25 -5,77 -60.18% | 11,4 14,9 -23.6% | -7,38 -5,31 -38.92% | -1,93 -5,11 62.15% | ||
|
EPS USD | Released Forecast Spread | -280 -217 -29.03% | 532 328 62.32% | -127 -74,0 -71.35% | -42,0 -50,8 17.32% | -98,8 -21,2 -366.04% | -12,3 -9,76 -26.33% | 4,91 5,75 -14.61% | -1,51 -2,04 25.98% | -0,30 -0,53 43.4% |
| Announcement Date | 04/11/21 | 16/03/22 | 05/05/22 | 11/08/22 | 08/11/22 | 23/02/23 | 11/05/23 | 16/08/23 | 20/11/23 |
More events
Past sector events for Baudax Bio, Inc.
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BXRXQ Stock
- Calendar Baudax Bio, Inc.
